In the ever-evolving landscape of pharmaceutical launches, the ability to collaborate in cross-functional teams effectively is key to not only achieving a successful launch but also ensuring long-term cross-asset impact through learning. In this session, Will will explore strategies that enable organizations to learn from each launch, harness cross-functional synergy, and maintain momentum post-launch. Discover how to fail fast, share successes, and course-correct swiftly to maximize impact and keep learning as a unified company.

• Creating a culture of continuous learning by integrating post-launch insights across therapy areas and teams and having the needs of the customer aligned to the value offered by a newly launched product.

• Promoting cross-functional and cross-company collaboration to share successes and quickly address challenges.

• Exploring agile practices that allow for rapid course correction and ongoing refinement of strategies.

Artificial Intelligence (AI) is transforming pharmaceutical launch strategies by enhancing decision-making, optimizing processes, and predicting market trends. As the pharmaceutical industry evolves, integrating AI into launch strategies is becoming increasingly essential for success. This session will delve into how AI can optimize launch planning, execution, and post-launch analysis, offering insights into its transformative potential.

• Leveraging AI for predictive analytics to forecast market trends and inform strategic decisions.

• Utilizing AI-driven tools to streamline operations, reducing time and costs in the launch process.

• Implementing AI in personalized marketing strategies to better engage and retain target audiences.

• Discussing how Generative AI will affect healthcare systems, patient care, patient access, decision making & how we can adapt to these predictions.